Docoh
Loading...

TMO Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Its Mission is to enable our customers to make the world healthier, cleaner and safer. Whether the customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, the company is here to support them. Its global team of more than 75,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

Company profile

Ticker
TMO
Exchange
CEO
Marc Casper
Employees
Incorporated
Location
Fiscal year end
Former names
THERMO ELECTRON CORP
SEC CIK
IRS number
42209186

TMO stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

24 Feb 21
2 Mar 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
26 Feb 21 Boxer Michael A Common Stock Payment of exercise Dispose F No No 450.08 257 115.67K 11,719
26 Feb 21 Peter E Hornstra Common Stock Payment of exercise Dispose F No No 450.08 69 31.06K 1,962
26 Feb 21 Syed A. Jafry Common Stock Payment of exercise Dispose F No No 450.08 1,139 512.64K 22,349
26 Feb 21 Michel Lagarde Common Stock Payment of exercise Dispose F No No 450.08 570 256.55K 24,574.205
26 Feb 21 Mark Stevenson Common Stock Payment of exercise Dispose F No No 450.08 2,251 1.01M 62,302
25 Feb 21 Boxer Michael A Common Stock Payment of exercise Dispose F No No 451.47 288 130.02K 11,976
25 Feb 21 Peter E Hornstra Common Stock Payment of exercise Dispose F No No 451.47 59 26.64K 2,031
25 Feb 21 Peter E Hornstra Common Stock Payment of exercise Dispose F No No 451.47 28 12.64K 2,090
25 Feb 21 Syed A. Jafry Common Stock Payment of exercise Dispose F No No 451.47 790 356.66K 23,488
25 Feb 21 Michel Lagarde Common Stock Payment of exercise Dispose F No No 451.47 1,025 462.76K 25,144.205
86.2% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 1929 1806 +6.8%
Opened positions 243 177 +37.3%
Closed positions 120 72 +66.7%
Increased positions 708 611 +15.9%
Reduced positions 718 746 -3.8%
13F shares
Current Prev Q Change
Total value 159.61B 160.03B -0.3%
Total shares 341.71M 346.09M -1.3%
Total puts 2.42M 1.46M +65.7%
Total calls 2M 1.18M +69.1%
Total put/call ratio 1.2 1.2 -2.0%
Largest owners
Shares Value Change
Vanguard 31M $14.44B -0.8%
BLK Blackrock 29.5M $13.74B +2.2%
Capital World Investors 15.98M $7.44B -0.3%
STT State Street 15.78M $7.35B -3.2%
FMR 13.02M $6.07B +5.6%
Massachusetts Financial Services 12.75M $5.94B -5.6%
TROW T. Rowe Price 12.56M $5.84B -10.1%
Capital Research Global Investors 9.94M $4.63B -14.2%
MS Morgan Stanley 7.73M $3.6B +4.4%
Wellington Management 7.3M $3.4B -5.5%
Largest transactions
Shares Bought/sold Change
Capital Research Global Investors 9.94M -1.64M -14.2%
TROW T. Rowe Price 12.56M -1.41M -10.1%
Viking Global Investors 77.82K -1.3M -94.3%
Massachusetts Financial Services 12.75M -756.09K -5.6%
BAC Bank Of America 6.69M -700.26K -9.5%
FMR 13.02M +686.77K +5.6%
Winslow Capital Management 631 -675.34K -99.9%
Capital International Investors 930.05K -633.64K -40.5%
BLK Blackrock 29.5M +624.51K +2.2%
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 1.27M -545.34K -30.0%

Financial report summary

?
Management Discussion
  • Sales in 2020 were $32.22 billion, an increase of $6.68 billion from 2019. Sales increased $78 million due to acquisitions, net of a divestiture. The favorable effects of currency translation resulted in an increase in revenues of $133 million in 2020. Aside from the effects of acquisitions and currency translation, revenues increased $6.47 billion (25%) primarily due to increased demand. Sales of products that address COVID-19 testing and treatment totaled $6.63 billion in 2020, and were offset in part by lower revenues in the remainder of the business during the first half of 2020. Sales were particularly strong in diagnostic and healthcare markets, due to demand for products supporting customers diagnosing the COVID-19 virus, offset in part by lower sales of other products due to pandemic-related impacts on customer activity. Sales were also strong to customers in pharma and biotech markets where demand was strong for products and services and pandemic-related demand for therapies and vaccines also contributed to growth. Sales to customers in industrial markets decreased primarily due to lower demand from weakened economic conditions related to COVID-19. Sales to these customers returned to positive growth in the fourth quarter of 2020. Sales to academic and government customers decreased due primarily to closure of academic labs during the global pandemic. Sales to these customers returned to positive growth in the third quarter of 2020. Sales growth was particularly strong in North America and Europe and, to a lesser extent, in the Asia-Pacific region.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: accident, Africa, Alexandra, announced, attract, attractive, belong, bioscience, breakdown, Brexit, broaden, buy, capability, career, chlorinated, choice, coaching, collaborate, colleague, commuter, companion, consecutive, contemporary, count, crossed, delinquency, dental, disability, disallowed, driven, dye, dynamic, East, Embracing, EMEA, empowered, empowering, ERG, ethnic, ethnicity, excellent, fabric, factory, feedback, feel, gave, gender, Graduate, greatly, hamper, home, Hong, inclusion, inclusive, Influenza, journey, Keith, kind, Kong, launched, leadership, learn, learning, LGBTQ, LIBOR, link, mentoring, Mesa, Middle, mobilized, mortality, motivator, notice, Novasep, onboarding, online, openly, organizational, outflow, outlined, overarching, passionate, perfluorooctanoic, persist, perspective, play, PPE, precautionary, prioritize, prolonged, proven, ramping, recruiting, recruitment, referral, regularly, reinforce, reopen, representation, respiratory, roadmap, role, rotational, SAS, scarce, similarly, situation, size, slowdown, solicit, spectral, spread, stake, Strep, stretch, strive, strongest, successful, successor, sulfonate, summer, syncytial, talent, temporarily, today, true, tuition, Twentieth, unpredictable, unrivaled, vaccine, valuable, vital, voice, worsen, woven
Removed: accreted, added, Affymetrix, alleged, alleging, allocate, appeal, ascribed, Asia, backlog, biopharmaceutical, bridge, Circuit, combined, community, complaint, consisting, correct, customizable, cytology, Delaware, developer, differential, disposing, District, effected, Elaine, expiring, FEI, filled, financed, forma, fully, histology, injunctive, installed, integration, invalid, investigate, IP, largely, meant, necessarily, noncancelable, operative, partial, percentage, plaintiff, preceding, preliminary, pro, promised, provisionally, qPCR, recording, refinancing, relief, remeasured, remediate, rental, revaluing, Southern, Supreme, title, Ullian, unaudited, unconditionally, unidentified, Unisone, unknown, volatile, waste